The global single-use bioprocessing market is expected to witness significant growth in the coming years, driven by a surge in demand for biologics and advancements in bioprocessing technologies. According to a recent market analysis, the market size was estimated at USD 9.1 billion in 2022 and is projected to reach USD 41.5 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 20.9% during the forecast period (2023-2030).
Key Players
The major key players are Sartorius AG, Danaher Corp., Thermo Fisher Scientific, Inc., Merck KGaA, Avantor, Inc., Eppendorf SE, Corning Inc., Boehringer Ingelheim International GmbH, Lonza, Infors AG, PBS Biotech, Inc., and Others.
Market Analysis:
The growth of the single-use bioprocessing market is attributed to several key factors, including:
- Rising Demand for Biologics: Biologics, a class of drugs derived from living organisms, are increasingly being used to treat a wide range of diseases. The efficacy and safety profiles of biologics are driving their adoption, creating a demand for efficient and cost-effective bioprocessing solutions.
- Technological Advancements: Continuous advancements in single-use bioprocessing technologies are improving efficiency, reducing costs, and minimizing contamination risks. These advancements are making single-use systems a more attractive option for biopharmaceutical manufacturers.
- Increased Focus on Flexibility and Scalability: Single-use bioprocessing systems offer greater flexibility and scalability compared to traditional stainless-steel systems. This allows manufacturers to adapt their production processes quickly and efficiently to meet changing market demands.
KEY SEGMENTS
By Product
- Work Equipment
- Apparatus & Plants
- Simple & Peripheral Elements
By Workflow
- Upstream Bioprocessing
- Fermentation
- Downstream Bioprocessing
By End User
- Biopharmaceutical & Pharmaceutical companies
- Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
- Academic & Research institutes
Impact of the Russia-Ukraine Conflict:
The ongoing conflict between Russia and Ukraine is expected to have a moderate impact on the single-use bioprocessing market. Disruptions in the supply chain for raw materials and equipment, particularly from Europe, could lead to temporary price fluctuations. However, the long-term growth prospects of the market remain positive.
The Economic Slowdown:
A potential economic slowdown could lead to budget constraints for biopharmaceutical companies, potentially impacting their investments in new technologies. However, the essential nature of biologics for healthcare is likely to mitigate the impact of an economic downturn on the single-use bioprocessing market.
Regional Analysis:
The North American region is expected to hold the largest market share throughout the forecast period due to the presence of a well-established biopharmaceutical industry and significant government support for research and development activities. However, the Asia Pacific region is expected to witness the fastest growth rate due to rising investments in biopharmaceutical infrastructure and increasing demand for biologics.
Key Takeaways:
- The single-use bioprocessing market is on track for significant growth, driven by the increasing demand for biologics and advancements in technology.
- While the Russia-Ukraine conflict and a potential economic slowdown may pose some challenges, the long-term growth prospects of the market remain promising.
- The market is expected to witness strong growth in the Asia Pacific region due to rising investments and increasing demand for biologics.
Other Trending Report
Platelet Rich Plasma Market Share
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com